NCT01149850: A reported trial by Jonsson Comprehensive Cancer Center
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT01149850 |
|---|---|
| Title | Phase II Study of Bevacizumab and Temozolomide in Elderly Patients With Newly-Diagnosed Glioblastoma |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | April 28, 2010 |
| Completion date | Dec. 8, 2023 |
| Required reporting date | Dec. 7, 2024, midnight |
| Actual reporting date | Oct. 31, 2024 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |